跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 387 条关于
“ImmBio”
全部
387
临床试验
247
药物
68
机构
13
资讯
59
去年
iiCON-Supported Phase II Trial Aims to Combat Pneumococcal Disease with Novel Vaccine
去年
iiCON-Supported Phase II Trial to Advance Novel Pneumococcal Vaccine, PnuBioVax
去年
TiumBio Doses First Patient in Phase 2 Trial of Oral Immuno-Oncology Drug TU2218
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
2年前
MAIA Biotechnology Completes Enrollment in Phase 2 THIO-101 Trial for Advanced NSCLC
11年前
AstraZeneca Expands Immuno-Oncology Portfolio with Three Strategic Partnerships
2年前
IN8bio Pauses INB-400 Glioblastoma Trial to Focus on AML Program
去年
GIST and Genome & Company Identify CNTN4 as Novel Immuno-Oncology Target
11个月前
OncoC4 Secures $50 Million Series B Funding to Advance Immuno-Oncology Pipeline
去年
Iambic Therapeutics Showcases AI-Driven Drug Discovery Platform at Multiple Investor Conferences
第 1 页,共 6 页
上一页
下一页